RA CAPITAL MANAGEMENT, L.P. bought EVMN

February 17, 2026 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 35,868 shares of Evommune, Inc. at $27.88 per share, a transaction worth $1000.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
35,868
Price
$27.88
Total value
$1000.0K
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 17, 2026
Shares owned after2,710,293
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; Held directly by the Fund.

View the original Form 4 on SEC EDGAR